Yuyu Pharma, Inc. Q3 revenue KRW 37.0 billion, operating profit KRW 3.3 billion, down 34.4% from a year earlier
AI summary · Not investment advice
In the third quarter, the company sold KRW 37.0 billion of goods and earned KRW 3.3 billion from its main business, down 34.4% from a year earlier and 18.3% from the prior quarter.
Operating profit · 3 months
KRW 3.3 billion
Key facts
- Revenue (3 months)
- KRW 37.0 billion
- Net income (3 months)
- KRW 2.5 billion
- Period
- Q3 (cumulative 2026.01.01 ~ 2026.09.30)
- Revenue (prior-year 3 months)
- KRW 37.8 billion
- Revenue (year to date)
- KRW 109.2 billion
- Operating profit (prior-year 3 months)
- KRW 5.0 billion
- Operating profit (year to date)
- KRW 11.6 billion
- Net income (prior-year 3 months)
- KRW 4.3 billion
- Net income (year to date)
- KRW 9.4 billion
Commentary
AI commentary · Not investment advice
What happened
Yuyu Pharma filed its quarterly report for the third quarter of 2026, on a consolidated basis. Sales for the latest 3 months were KRW 36.98 billion. That is 2.1% lower than the same period a year earlier and 0.8% higher than the previous quarter.
In the company's terms
Operating profit (profit from the main business) for the 3 months was KRW 3.27 billion. That is 34.4% lower than a year earlier and 18.3% lower than the previous quarter. Net income (final profit after taxes and other costs) for the 3 months was KRW 2.48 billion. That is 42.7% lower than a year earlier and 30.4% lower than the previous quarter.
What changes for shareholders
For the cumulative period from January 1 to September 30, 2026, sales were KRW 109.22 billion. Operating profit was KRW 11.58 billion, and net income was KRW 9.38 billion.
Comments
No comments yet
Comments from shareholders will appear here.
Ad
Verify your holdings and catch the next disclosure
Verify the stocks you hold and get new disclosures as app alerts.

App design sample
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist
Y